DAB2IP and prostate carcinoma: DAB2IP (DOC2/DAB2 interactive protein), a member of the RAS-GTPase-activating protein (RAS-GAP) family [6], is downregulated in several cancer types, such as prostate cancer, bladder cancer, hepatocellular cancer, and colorectal cancer [7–10].